Imprimis NJOF, LLC is recalling 4,280 boxes of its Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension (1%, 0.5%, 0.075%). These prescription eye drops are being recalled due to a lack of assurance of sterility, which means the product may not be free from microorganisms. Consumers who have used this compounded medication should monitor for signs of infection and contact their doctor or pharmacist.
A lack of sterility in eye drops poses a risk of bacterial or fungal infection. Such infections can cause serious injury to the eye, including inflammation and potential permanent vision loss.
You have 2 options:
Compounded by: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ. Recall #: D-0548-2024.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.